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Leuven, Campus Gasthuisberg, Leuven, BelgiumBACKGROUND & AIMS: Coping resources and processes are altered in patients with irritable bowel syndrome (IBS). We
investigated the relationship between coping resources and gastrointestinal (GI) and extra-
intestinal symptom severity in patients with IBS and potential mediators of this relationship.METHODS: We performed a cross-sectional study of 216 patients with IBS attending a secondary/tertiary
care specialized outpatient center in Sweden from 2003 through 2007. We collected data on
coping resources, levels of anxiety (general and GI specific), depressive symptoms, levels of GI
symptoms, and extraintestinal somatic symptoms (somatization) by administering validated self-
report questionnaires. General Linear Models were used to assess associations and mediation.RESULTS: GI symptoms: low levels of physical coping resources (practice of activities that are beneficial for
health; P[ .0016), high levels of general anxiety symptoms (P[ .033), and GI-specific anxiety
symptoms (P < .0001), but not depressive symptoms (P[ .89), were independently associated
with GI symptom levels (R2[ 0.31). Anxiety and GI-specific anxiety partially mediated the effect
of physical coping. Somatization: low levels of physical coping resources (P[ .003), high levels
of anxiety (P[ .0147), depressive (P[ .0005), and GI-specific anxiety symptoms (P[ .06) were
associated with somatization levels (R2 [ 0.35). Levels of general and GI-specific anxiety and
depressive symptoms partially mediated this physical coping effect. The effect of psychological
coping resources (including optimism, social support, and accepting/expressing emotions) on
somatization levels was not significant (P[ .98), but was fully mediated by levels of anxiety and
depressive symptoms, and partially by levels of GI-specific anxiety symptoms.CONCLUSIONS: In a cross-sectional study of patients with IBS in Sweden, we found associations of levels of
coping resources with GI and extraintestinal symptom severity; these associations were
mediated by levels of anxiety and depressive symptoms. Although confirmation in longitudinal
studies is needed, this identifies coping as a potential psychological treatment target in IBS.Keywords: Functional Disorders; Coping Resources; Anxiety; Depression; Somatization.See editorial on page 1500.
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stood, but it is generally accepted that dysfunction of
brain-gut signaling plays a key role.1 Peripheral factors,
including immunologic, microbiologic, and neuroendo-
crine, affect afferent signals conveyed along the brain-
gut axis,2 which in turn are centrally modulated bypsychological processes, such as attention toward and
fear of bodily/gastrointestinal (GI) symptoms, and
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disorders.1 The brain-gut axis therefore provides the
necessary biologic framework to support a bio-
psychosocial conceptualization of IBS. More specifically,
these psychobiologic processes may underlie the
relationship between psychological processes or states
and reporting of (medically unexplained) GI or, more
broadly, somatic symptoms.3
Within this biopsychosocial conceptualization, the
previously mentioned psychological processes have been
studied extensively, whereas others, including coping re-
sources, have received relatively little attention.3 Coping
can be defined as a process consisting of action-oriented
and intrapsychic efforts to manage the demands created
by stressful events.4,5 Coping resources, including rela-
tively stable individual differences in optimism, social
support, acceptance and expression of emotions (psy-
chological coping resources), and the tendency to practice
activities that are beneficial for health, including physical
exercise and eating healthy foods (physical coping re-
sources) can aid in this process, and in turn affect coping
processes. Coping efforts can be adaptive or maladaptive
(ie, result in successful resolution of a stressor or not, and
coping resources and processes have been shown to affect
both physical and mental health.4,6 Altered levels of
coping resources have been reported in IBS and other
functional GI disorders compared with healthy or organic
disease control populations.7–11 However, these studies
were case-control studies, and few studies have evaluated
the relationship between levels of coping resources on the
one hand and levels of GI and extraintestinal somatic
symptoms on the other, taking the levels of psychological
symptoms into account.12
Multiple (medically unexplained) extraintestinal
somatic symptoms, such as headache, musculoskeletal
pain, and urinary symptoms, are frequent in IBS,13 and
the collective severity of these symptoms is often
quantified and referred to as “somatization.”14,15 An as-
sociation between levels of somatization, GI symptoms,
self-ratings of health, and number of health care visits
has been demonstrated in IBS,16,17 and the type of co-
morbid somatic symptoms is associated with distress
and reduction of quality of life.18 Moreover, comorbidity
with anxiety disorders and depression among patients
with IBS is high.19 Furthermore, levels of symptom-
specific anxiety have been shown to be associated with
higher somatic symptom severity in chronic pain disor-
ders in general,20 and in patients with IBS specifically.21
Thus, altered levels of coping resources, and increased
levels of anxiety and depressive symptoms, and extra-
intestinal somatic symptoms (ie, somatization), have all
been described in IBS, but the relationship between these
features remains understudied. We therefore aimed to
study the association between levels of coping resources
on the one hand, and GI symptoms and somatization on
the other, in IBS. Somatization was used as an outcome in
addition to GI symptom severity to elucidate whether the
relationships found are specific to the core GI symptomsof IBS, or generalize to somatic symptom reporting in
general.We hypothesized an association between levels of
coping resources and levels of both somatic symptom
reporting in general (somatization) and GI symptoms
more specifically, because coping resources have been
linked to awide variety of physical health outcomes rather
than specific ones.4 We also hypothesized that these pu-
tative associations would be mediated by levels of
depressive and (GI symptom-specific) anxiety symptoms,
based on longitudinal evidence demonstrating that lower
levels of coping resources may lead to increased levels of
anxiety and depression symptoms,22,23 which are in turn
associated with IBS diagnosis and somatization.24
Furthermore, levels of coping resources are considered
to be relatively stable over time (“trait” characteristics),
contrary to levels of anxiety and depressive symptoms
(“state” characteristics).4,6
Materials and Methods
Study Population and Data Collection
Patients aged 18–70 years fulfilling the ROME II
criteria25 for IBS were recruited from 2 studies with the
main objective to investigate pathophysiology and
symptoms.26,27 The patients were included between
2003 and 2007 at a secondary/tertiary care outpatient
center specialized in functional GI disorders.
Self-Assessment Questionnaires
The patients completed the following validated self-
assessment questionnaires in privacy on site at their
first study visit to assess coping resources, psychological
and GI symptoms, and somatization: Coping Resources
Inventory (CRI),6 Gastrointestinal Symptom Rating
Scale,28 Hospital Anxiety and Depression Scale,29 Visceral
Sensitivity Index,30 and Symptom Check List-90
Revised.31 In this study we only used the somatization
subscale of Symptom Check List-90 Revised. For detailed
descriptions of these questionnaires, see the
Supplementary Material.
Statistical Methods
Details of statistical methods are provided in the
Supplementary Material. Briefly, the number of subscales
of the CRI was first reduced using factor analysis. The
resulting factor scores were associated with GI symptom
severity and somatization using bivariate Pearson corre-
lations and 2 stepwise General Linear Model analyses
(step 1, coping resources; step 2, general and symptom-
specific anxiety, depression), 1 for each of the outcomes
(GI symptom severity, somatization). Putative mediation
of the effect of coping resources on GI symptom severity
and somatization by psychological state variables was
tested using the Baron and Kenny method.
Table 2. Bivariate Associations: Coping Factors,
Somatization, GI, and Psychological Symptoms
Factor 1:
psychological
coping
Factor 2:
spiritual
coping
Factor 3:
physical
coping
GI symptoms (GSRS) -0.02 -0.05 -0.31a
Somatization (SCL-90R) -0.24a 0.01 -0.34a
Anxiety (HADS) -0.32a -0.23a -0.19b
Depression (HADS) -0.53a -0.09 -0.25a
GI-specific anxiety (VSI) -0.22b -0.11 -0.20b
Pearson correlation coefficients: aP < .001, bP < .01.
GSRS, Gastrointestinal Symptom Rating Scale; HADS, Hospital Anxiety and
Depression Scale; SCL-90R, Symptom Check List-90 Revised; VSI, Visceral
Sensitivity Index.
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Subjects
We included 250 patients with IBS and after exclu-
sions caused by incomplete completion of question-
naires, 216 patients with IBS remained for the analyses
in this study. There were no significant differences in
gender (distribution prior/post exclusion: 177/151
female and 73/65 male) or age (mean age prior/post
exclusion: 40.0/40.4 years) distribution after exclusions.
For more extensive information on the study population,
see the Supplementary Material. Descriptive results of
the 5 subscales of CRI, Hospital Anxiety and Depression
Scale, Visceral Sensitivity Index, and Gastrointestinal
Symptom Rating Scale, including the proportion of sub-
jects with clinically significant anxiety and depression
using validated cutoff levels,29 are displayed in
Supplementary Table 1.
Factor Analysis
In a factor analysis on the 5 CRI subscales scores, 3
factors were retained, jointly explaining 88% of the
variance (Table 1). The interpretation of the resulting
factors was straightforward. Factor 1 was termed “psy-
chological coping” because the cognitive, social, and
emotional CRI subscales showed high loadings on this
factor. Factor 2 “spiritual coping” and Factor 3 “physical
coping” were both characterized by high loadings of the
single respective CRI subscales only. Cross-loadings were
low (all < 0.33).
Bivariate Associations
Better physical coping was associated with lower
levels of GI symptom severity (r ¼ -0.31; P < .0001),
whereas lower levels of both psychological (r ¼ -0.24;
P ¼ .0004) and physical coping resources (r ¼ -0.34;
P< .0001) were associated with more severe somatization
(Table 2). More severe general anxiety was associated
with lower levels of psychological (r ¼ -0.32; P < .0001),
spiritual (r ¼ -0.23; P ¼ .0001), and physical copingTable 1. Results of Factor Analysis of CRI: Rotated Factor
Pattern
Coping,
subscale
Factor 1:
psychological
coping
Factor 2:
spiritual
coping
Factor 3:
physical
coping
Cognitive 0.75 0.32 0.31
Social 0.91 0.15 0.09
Emotional 0.87 0.23 0.13
Spiritual 0.29 0.95 0.05
Physical 0.18 0.05 0.98
NOTE. The numbers in the table are factor loadings.(r ¼ -0.19; P ¼ .007). More severe depression and
GI-specific anxiety were associated with lower levels of
psychological (r ¼ -0.53, P < .0001; and r ¼ -0.22,
P ¼ .002, respectively) and physical coping resources
(r ¼ -0.26, P ¼ .0002; and r ¼ -0.20, P ¼ .005, respec-
tively) (Table 2).General Linear Models and Mediation Analyses
Outcome 1: gastrointestinal symptom severity
(Gastrointestinal Symptom Rating Scale)
First step: Level of physical coping resources was
significantly associated with GI symptom severity
(Table 3).
Second step: When adding levels of general and GI-
specific anxiety, and depressive symptoms as covariates
to the model, indication of (partial) mediation was found,
because the significance of the relationship between level
of physical coping resources and GI symptom severity
was reduced (Table 3). The effects of level of physical
coping resources, and of general and GI-specific anxiety
symptoms, were significant, whereas the effect of level
depressive symptoms was not. The variables in the
model jointly explained 31% of the variance in GI
symptom severity.
Mediation analyses: The effect of level of physical
coping resources on GI symptom severity was partiallyTable 3.GLMs for GI Symptom Severity
b  SE Fvariable Pvariable
GLM step 1a
Physical coping -0.26  0.1 22.08 < .0001
GLM step 2b
Physical coping -0.17  0.05 10.31 .0016
Anxiety 0.033  0.015 4.63 .0327
Depression 0.003  0.018 0.02 .89
GI-specific anxiety 0.018  0.004 24.45 < .0001
GLM, General Linear Model.
aModel: F1,206 ¼ 22.08; P < .0001; R2 ¼ 0.10.
bModel: F4,190 ¼ 21.14; P < .0001; R2 ¼ 0.31.
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P ¼ .017) and GI-specific anxiety (z ¼ 2.64; P ¼ .008)
symptoms (details for GI-specific anxiety in Figure 1A,
details not shown for general anxiety). When the position
of the independent (coping) and mediator (anxiety)
variables were flipped, level of physical coping resources
was found to partially mediate the effects of both levels
of general (z ¼ 2.23; P ¼ .026) and GI-specific anxiety
(z ¼ 2.21; P ¼ .027) symptoms on GI symptom severity,
thereby providing evidence for the alternative path with
level of physical coping resources as the mediator rather
than independent variable.
Outcome 2: somatization (Symptom Check List-90
Revised)
First step: Levels of physical and psychological coping
resources were independently associated with somati-
zation (Table 4).
Second step: When adding levels of anxiety (general
and GI-specific) and depressive symptoms as covariates
to the General Linear Model, the effect of level of psy-
chological coping resources became nonsignificant andalso the strength of the effect of level of physical coping
resources was reduced, although still significant, giving
an indication of full and partial mediation, respectively.
The effects of levels of physical coping resources, and of
general anxiety and depression symptoms, were signifi-
cant, whereas the effect of level of GI-specific anxiety
symptoms showed a trend (P ¼ .06). The variables in the
model jointly explained 35% of the variance in somati-
zation levels (Table 4).
Mediation analyses: The effect of level of psycho-
logical coping resources on somatization was fully
mediated by levels of anxiety (Sobel test: z ¼ 3.78;
P ¼ .0001) and depressive (z ¼ 5.63; P < .0001)
symptoms, and partially mediated by levels of GI-
specific anxiety symptoms (z ¼ 2.73; P ¼ .006) levels
(details for level of depressive symptoms shown in
Figure 1B).
The effect of level of physical coping resources on
somatization was partially mediated by levels of anxiety
(Sobel test: z ¼ 2.50; P ¼ .012), depressive (z ¼ 3.33;
P ¼ .0008), and GI-specific anxiety (z ¼ 2.48; P ¼ .013)Figure 1.Mediation ana-
lyses where it is demon-
strated that (A) the
association between
physical coping and GI
symptom severity is
partially mediated by
GI-specific anxiety (Sobel
test for significance of in-
direct effect: z ¼ 2.64;
P ¼ .008), (B) the associ-
ation between psycholog-
ical coping and
somatization is fully medi-
ated by depression (Sobel
test for significance of in-
direct effect: z ¼ 5.63; P <
.0001), and (C) the associ-
ation between physical
coping and somatization is
partially mediated by
depression (Sobel test for
significance of indirect ef-
fect: z ¼ 3.33; P ¼ .0008).
GSRS, Gastrointestinal
Symptom Rating Scale;
SCL-90R, Symptom
Check List-90 Revised.
Table 4.GLMs for Somatization
b  SE Fvariable Pvariable
GLM step 1a
Psychological coping -1.8  0.5 14.76 .0002
Physical coping -2.53  0.5 28.75 < .0001
GLM step 2b
Psychological coping 0.014  0.55 0.00 .98
Physical coping -1.40  0.47 9.04 .003
Anxiety 0.33  0.13 6.06 .0147
Depression 0.64  0.18 12.44 .0005
GI-specific anxiety 0.06  0.03 3.57 .0604
GLM, General Linear Model.
aModel: F2,210 ¼ 21.80; P < .0001; R2 ¼ 0.17.
bModel F5,188 ¼ 19.90; P < .0001; R2 ¼ 0.35.
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Figure 1C). For further information on mediation ana-
lyses, see the Supplementary Material.Discussion
We demonstrated that lower levels of physical and
psychological coping resources are associated with
increased GI and extraintestinal somatic symptom
severity in IBS, and that these associations are (partially)
mediated by levels of anxiety and depressive symptoms.
However, evidence was also found for the alternative
path in which level of physical coping resources partially
mediates the effect of levels of anxiety and depressive
symptoms on GI symptom severity and somatization;
this was not the case for level of psychological coping
resources.
In IBS, both physiological and psychosocial factors are
believed to contribute to the occurrence and severity of
GI symptoms.32 Several studies have explored the
connection between psychosocial factors and IBS, but
research on the role of coping resources specifically is
sparse, and almost exclusively limited to what we in the
results refer to as psychological coping resources, con-
sisting of the cognitive, social, and emotional subscales of
the CRI. Specifically, patients with IBS have been found to
use a more emotionally focused coping style,10 and to
use positive reappraisal less frequently compared
with patients with organic GI diseases.33 Abnormalities
in coping style (more specifically, an inflexible, action-
oriented coping style, such as problem-solving and
confrontation) have been reported in patients with
functional dyspepsia (FD).34,35 It has also been shown
that maladaptive psychological coping strategies (spe-
cifically, catastrophizing and decreased self-perceived
ability to decrease symptoms) are predictors for
various indicators of poor health outcome in both func-
tional and organic GI disorders.33 Catastrophizing rep-
resents a maladaptive cognitive coping process that is
frequently present among patients with IBS.11 Cata-
strophizing is defined as “a negative cognitive process ofexaggerated negative rumination and worry,”36 which in
our study was best represented by the (inverse of) the
cognitive subscale of the CRI. Moreover, higher levels of
catastrophizing are associated with more severe pain
in IBS.11 In line with these findings, our study has
demonstrated that lower levels of psychological coping
resources, including the cognitive domain, were associ-
ated with higher levels of somatization (ie, levels of
painful extraintestinal symptoms).
Furthermore, we demonstrated that level of physical
coping resources in patients with IBS was independently
associated with GI symptom severity, and with somati-
zation. The association between level of physical coping
resources and GI symptom severity is of interest,
because a recent study from our group highlighted the
benefit of physical activity for IBS symptoms,37 with
physical activity being an important component of
physical coping resources. Moreover, there is growing
evidence that adopting a “healthier” diet, another
important component of physical coping resources, even
without specifically restricting certain nutrients, im-
proves IBS symptoms.38 To the best of our knowledge,
the specific effects of physical coping resources have not
been studied before in IBS.
Moreover, the existing studies where impaired levels
of (psychological) coping resources in IBS have been
documented and linked to health outcomes have evalu-
ated coping as a separate factor, without taking interac-
tion with other potentially relevant factors into
account.33,39 Although the frequent presence of anxiety
and depressive symptoms in IBS is well known,40,41 the
role of levels of anxiety and depressive symptoms in the
association between coping strategies and symptoms in
IBS has not previously been investigated. In FD, however,
it has been shown that anxiety and depression are
associated with impaired coping.34,35,42
The effect of level of physical coping on both GI
symptom severity and somatization was partially medi-
ated by levels of anxiety and depressive symptoms. This
is in line with a large body of evidence showing that
physical exercise and dietary interventions (which
constitute important components of physical coping re-
sources) can reduce levels of anxiety and depressive
symptoms.43,44 However, we also found evidence for an
alternative path in which level of physical coping re-
sources acts as the mediator of the psychological-
somatic symptom relationship. It is indeed conceivable
that physical coping resources are less stable over time
compared with psychological coping resources, and
there is evidence that depressive episodes are associated
with a less healthy lifestyle, both in terms of physical
exercise and diet.45 Moreover, level of psychological
coping resources was, independent of physical coping,
associated with somatization, but this effect was fully
mediated by levels of depressive and general anxiety
symptoms. No evidence for an alternative path model
with level of coping resources as the mediator was found
here, which is in line with the conceptualization of
1570 Wilpart et al Clinical Gastroenterology and Hepatology Vol. 15, No. 10(psychological) coping resources as a stable trait pre-
disposing to various negative psychological and somatic
health outcomes.4
Although sufficient caution is warranted, because our
findings need to be confirmed in longitudinal studies,
they may have implications toward IBS treatment.
Because coping is not an innate capacity, but can change
over time,5 strengthening coping resources could poten-
tially improve symptoms in patients with IBS. Previous
research in FD may serve as an example here. The finding
of a nondiscriminative, inflexible coping style,34,35 defined
as “the ability to discontinue an ineffective coping strat-
egy and produce and implement an alternative coping
strategy,”46 led to the development of a specific inter-
vention to improve coping flexibility. It was shown that
such “flexible coping psychotherapy” not only improved
coping flexibility, but also FD symptoms, and that the
improvement on both these parameters correlated.
This study has several limitations that should be
addressed. First, mediation in the strict sense requires
temporal precedence of the mediator by the mediated
variable.47,48 Because this study is cross-sectional, we do
not have temporal precedence, and the order of variables
in the regression model is therefore based on theoretical
and empirical grounds from the existing literature
rendering this chronological order plausible.22–24 The
cross-sectional design restricts from conclusions being
drawn regarding the temporal order of events and,
hence, regarding causality. Confirmation of these results
in longitudinal studies is therefore needed, especially
regarding the results on physical coping resources,
because we found evidence supporting an alternative
path model in which level of physical coping resources
mediates the effect of levels of anxiety and depressive
symptoms on somatic symptom severity. Furthermore,
because this study did not include any control group, we
cannot conclude whether these findings are specific to
patients with IBS or equally apply to other patient
groups characterized by (medically unexplained) GI and/
or extraintestinal symptoms, and our findings from a
secondary/tertiary care IBS population cannot be
generalized to a primary care population. Finally, we
only tested a limited number of potentially relevant
mediators; hence, additional ones may need to be taken
into account in future studies (eg, symptom-specific
psychological processes such as health-related or pain-
specific anxiety).
Despite these limitations, our results identify coping
resources as a relevant factor associated with GI and
extraintestinal symptom severity in IBS. Both compo-
nents of the mediational pathway, impaired coping and
anxiety and depression levels, may thus serve as poten-
tial targets for improving somatic symptoms in IBS.
However, the effect of physical coping is only partially
mediated through psychological symptom levels; there-
fore, it may be useful to target both physical coping
mechanisms and psychological symptoms to improve
somatic symptom severity in IBS.Supplementary Material
Note: To access the supplementary material accom-
panying this article, visit the online version of Clinical
Gastroenterology and Hepatology at www.cghjournal.org,
and at http://dx.doi.org/10.1016/j.cgh.2017.02.032.References
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Study Population and Data Collection
Most patients were referred from primary care, and a
smaller proportion through self-referral or from gastro-
enterologists, and the diagnosis was based on a typical
clinical presentation and additional investigations if
considered necessary by the gastroenterologist (M.S.).
Exclusion criteria were other GI diseases explaining the
symptoms; severe diseases, such as malignancy, heart
disease, kidney disease, or neurologic disease; severe
psychiatric disease; or pregnancy. The studies were
approved by the Regional Ethical Review Board in
Gothenburg, Sweden. Each participant was verbally
informed about the study and was given written infor-
mation, before giving written informed consent to
participate in the studies.
Self-Assessment Questionnaires
 CRI1: One of the goals in developing the CRI was to
provide a tool for identifying resources currently
available to individuals for managing stress. Clinical
theory and practice largely focus on what is wrong
with people rather than on what is right with them.
The CRI was constructed to facilitate an emphasis on
resources rather than deficits.1 The CRI consists of 60
statements, subdivided into 5 domains. The state-
ments are answered on an ordinal scale (1–4), ranging
from never or seldom to almost always or always. A
score for each domain and a total CRI score can be
calculated by summing up the respective items. The
different domains reflect the ability of an individual to
respond to, handle, and recover from stressful
situations.
B Cognitive: how generally optimistic the individual is,
and to what extent the person keeps a positive
outlook on oneself and toward others. Example
statement: “I feel as valuable as anyone else.”
B Social: to what extent the person belongs to a social
context that is supportive in stressful situations.
“I am part of a group, other than my family that cares
about me.”
B Emotional: to what extent the person can accept and
express a variety of emotions, based on a principle
that the long-term negative effects of stress can be
soothed with the help of emotional responses. “I can
cry when I am sad.”
B Spiritual: to what extent the actions of the individual
are driven by personal convictions or religious,
familial. or cultural traditions. These traditions may
aid in stressful situations by giving them a purpose
and provide ways of effective responses. “I know
what is important in life.”B Physical: to what extent the person exercises and
takes part in activities that promote physical health.
It is believed that a high level of physical well-being
decreases negative stress reactions and aids in a
faster recovery. “I exercise vigorously 3 to 4 times a
week.”1
 Hospital Anxiety and Depression Scale2: Assesses the
presence and severity of anxiety and depression
symptoms during the past week by 7 questions on each
domain, and is specifically designed to be used in
nonpsychiatric settings. Each response is scored 0–3,
with 3 indicating the most severe symptom level. The
scores for anxiety and depression are calculated
separately and each have a range of 0–21.2
 Visceral Sensitivity Index3: A widely used and well-
validated measurement of anticipatory anxiety con-
cerning the likely occurrence of GI symptoms.3–5 Five
dimensions of GI symptom-specific anxiety (worry,
fear, sensitivity, attentiveness, and avoidance) are
investigated through 15 statements that are assessed
through a 6-point Likert scale, ranging from strongly
agree to strongly disagree. The scores range from 0 to
75, with a higher score indicating more severe the GI
symptom–specific anxiety.3,5
 Gastrointestinal Symptom Rating Scale6: A reliable
instrument to assess distinct groups of GI symptoms:
reflux, indigestion, abdominal pain, constipation, and
diarrhea. The questionnaire consists of 15 items, which
are scored on a 7-point Likert scale, ranging from no
symptoms (¼1) to very severe symptoms (¼7). A
higher score indicates more severe symptoms.
 Symptom Check List-90 Revised7: Evaluates a wide
variety of psychological symptoms and distress. The
questionnaire covers 9 symptom dimensions (somati-
zation, obsessive-compulsive, interpersonal sensitivity,
depression, anxiety, hostility, phobic anxiety, paranoid
ideation, and psychoticism) through 90 statements.
Each statement is scored on a 5-point scale, ranging
from no symptoms (¼0) to extreme symptoms (¼4). A
higher score indicates more severe symptoms in that
dimension. The dimensions can also be added into 3
different global distress indices. In this study we only
used the somatization subscale. Somatization refers to
the tendency to experience and express psychological
distress as somatic symptoms and seek medical assis-
tance for the symptoms.
Statistical Methods
All analyses were done using SAS 9.1 software (SAS
Institute, Cary, NC). Data are presented as mean 
standard deviation; significance level was set at P < .05
(2-tailed). The number of subscales of the CRI was first
reduced through factor analysis on the 5 subscale scores
(principal components method, orthogonal varimax
October 2017 Coping, GI Symptoms, and Somatization in IBS 1571.e2rotation), thereby also orthogonalizing the resulting
factors to avoid multicollinearity when using them as
independent variables in subsequent General Linear
Model (GLM) analyses (see below). The criterion to
retain a factor was explained proportion of the variance
> 10%. Bivariate associations were explored between
the retained coping resources factors on the one hand,
and levels of GI symptoms, somatization, and (GI-specific
and general) anxiety and depression symptoms on the
other, using Pearson correlations.
Coping resources factors significantly associated with
GI symptom severity or somatization in bivariate corre-
lation analyses were further analyzed in 2 GLMs. The
coping resources factors were first entered as indepen-
dent variables in the respective GLM with GI symptom
severity and somatization as the dependent variables.
Secondly, levels of depressive, general and GI-specific
anxiety symptoms were added as covariates.
Traditionally mediation requires temporal prece-
dence of the mediator by the independent variable8,9;
mediation was thus used in a more restricted sense in
this cross-sectional study. However, the order in which
the variables were entered in the GLM was chosen ac-
cording to a plausible chronological order based on
theoretical and empirical grounds, as outlined in the
introduction. Furthermore, we tested alternative paths
by flipping the position of the independent and mediator
variables (ie, testing whether the effect of levels of anx-
iety and depressive symptoms on levels of GI symptoms
and somatization is mediated by levels of coping
resources).
The potential mediation effects of levels of general
anxiety, depressive, and GI-specific anxiety symptoms on
the coping resources (GI symptom severity and somati-
zation relationship) were tested using the Baron and
Kenny method, with the Sobel test for the significance of
the indirect effect.9 When investigating mediation, it is
required that the potential mediator is associated with
the independent variable, and that it significantly re-
duces the strength of the effect of this independent
variable on the dependent variable when added to the
model.8
Results: Somatization (Symptom Check
List-90 Revised) Mediation analyses
Psychological Coping Resources: Effect
on Somatization
The effect of level of physical coping resources on
somatization was partially mediated by levels of anxiety
(Sobel test: z ¼ 2.50; P ¼ .012), depressive (z ¼ 3.33;
P ¼ .0008), and GI-specific anxiety (z ¼ 2.48; P ¼ .013)symptoms (details for level of depressive symptoms in
Figure 1C).
When the position of the independent (coping) and
mediator (anxiety, depressive symptoms) variables were
flipped, no evidence for mediation was found (effect of
the mediator nonsignificant, strength of effect of the in-
dependent variable not reduced), arguing against the
alternative path with level of psychological coping re-
sources as the mediator rather than the independent
variable.
Physical Coping Resources: Effect
on Somatization
When the position of the independent (coping) and
mediator (anxiety, depression) variables were flipped,
level of physical coping resources was found to partially
mediate the effects of levels of general anxiety (z ¼ 2.30;
P ¼ .021), depressive (z ¼ 2.65; P ¼ .008), and GI-
specific anxiety symptom levels (z ¼ 2.30; P ¼ .022)
on somatization, thereby providing evidence for the
alternative path with level of physical coping resources
as the mediator rather than the independent variable.References
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Supplementary Table 1. Results From Questionnaires in
Patients With IBS Measuring
Coping Resources, Anxiety
(General and GI-Specific),
Depression, and GI and
Extraintestinal Symptoms (n ¼ 250)
Mean (SD) Min. Max.
CRI, cognitive 27.2 (5.0) 11 36
CRI, social 40.4 (5.7) 23 52
CRI, emotional 45.3 (8.0) 24 63
CRI, spiritual 27.5 (5.2) 13 43
CRI, physical 27.6 (4.8) 13 38
HADS, anxietya 7.1 (4.3) 0 20
HADS, depressionb 4.8 (3.5) 0 16
VSI 34.6 (16.6) 4 72
SCL90-R, somatization 11.2 (7.6) 0 36
GSRS, total 3.2 (0.84) 1.2 5.4
GSRS, Gastrointestinal Symptom Rating Scale; HADS, Hospital Anxiety and
Depression Scale; SCL-90R, Symptom Check List-90 Revised; SD, standard
deviation; VSI, Visceral Sensitivity Index.
a43 of 250 (17.2%) patients had HAD anxiety score >10, hence clinically
significant anxiety.
b17 of 250 (6.8%) patients had HAD depression score >10, hence clinically
significant depression.
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